CARNEY JUST LOCKED THE VAULT ON CANADA'S DRUG SUPPLY. 3.7 MILLION U.S. PATIENTS ARE NOW STRANDED

 

 

#TheDecisionRoom #CanadaTariffs #MarkCarney

 

What if the country America was supposed to siphon cheap pills from simply refused, and the plan died? At 4:30 we go inside the 2020 ministerial order that walked Washington out of an $603 billion drug-pricing fantasy. At 9:10 we trace the 1987 Patented Medicine Prices Review Board statute to its 2025 restatement under Mark Carney. 

 

You will learn how Canada's PMPRB, Health Canada, provincial formularies, and the November 27, 2020 bulk-export block by Health Minister Patty Hajdu combined into a single architecture that protects Canadian patients while quietly exposing how dependent the United States is on a regulatory body it does not even have. You will understand why Trump returned to the same idea in 2025 as President, why the 200 percent pharmaceutical tariff threat triggered Carney's July 14 response, and why real cross-border pharmaceutical trade totals only about $9.5 billion Canadian dollars — a fraction of what the campaign trail implied. 

 

You will see the full U.S. structural vulnerability: $603 billion in prescription drug spend, generics 88 percent globally sourced, India supplying 30 percent of generic volume, China supplying 13 percent of active pharmaceutical ingredients, and 295 active shortage notices at the end of 2024. 

 

We break down Trump's Executive Order 13948 of July 24, 2020, the FDA Safe Importation Action Plan final rule of September 24, 2020, the parallel Pathways 1 and 2, the five states that lined up with waivers including Florida's $80 million projected savings target on 121 specific drugs, and the precise text of the order that ended the entire plan. Hosted by Ryan on The Decision Room. Subscribe and tap the bell for the next episode on Canada's structural leverage inside the U.S. prescription supply chain. 

 

 #TheDecisionRoom #CanadaTariffs #MarkCarney #TrumpImportPlan #PharmaSupplyChain #ColumbiaRiver #PattyHajdu

Source:       Senior Benefits Insider